The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
XTL Biopharmaceuticals Ltd(NASDAQ:XTLB) 
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome....
XTL Biopharmaceuticals Op Cashflow Per Share ttm
XTL Biopharmaceuticals Free Cashflow Per Share ttm
XTL Biopharmaceuticals Cash Per Share ttm
XTL Biopharmaceuticals P/S ratio ttm
XTL Biopharmaceuticals (GAAP) P/E ratio ttm
XTL Biopharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.